GABAPENTIN
- Product NDC
- 67296-1638
- 11-digit product format
- 672961638
- Labeler code
- 67296
- Product ID
- 67296-1638_b8d0a08f-8077-1f4e-e053-2a95a90a62e9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA090007
- Marketing category
- ANDA
- Marketing start
- 2019-01-01
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1638-2 | GABAPENTIN | 20 in 1 BOTTLE | CAPSULE | 20 | | 3 |
| 67296-1638-6 | GABAPENTIN | 60 in 1 BOTTLE | CAPSULE | 60 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1638 | GABAPENTIN CAPSULE [REDPHARM DRUG, INC.] | 3 | Legacy NDC, 2 package rows | 20210114_88ddd50d-1762-2880-e053-2995a90adf67.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1638-2 | 67296163802 | 20 CAPSULE in 1 BOTTLE (67296-1638-2) | 20 capsule | 2019-01-01 | 0000-00-00 | No | No | Current |
| 67296-1638-6 | 67296163806 | 60 CAPSULE in 1 BOTTLE (67296-1638-6) | 60 capsule | 2019-11-01 | 0000-00-00 | No | No | Current |